A comparison of four antiepileptic drugs in status epilepticus: experience from India

References

• Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205–10.
   PubMed Web of Science ®Google Scholar
• Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792–8.
   PubMed Web of Science ®Google Scholar
• Hesdorffer DC, Logroscino G, Cascino G, et al. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 1998;50:735–45.
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029–35.
   PubMed Web of Science ®Google Scholar
• Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French speaking Switzerland. Neurology 2000;55:693–7.
   PubMed Web of Science ®Google Scholar
• Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population based study. Epilepsia 2001;42:714–8.
   PubMed Web of Science ®Google Scholar
• Vignatelli L, Tonon C, D'Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003;44:964–8.
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J, Nair PP. Status epilepticus in central nervous system infections: an experience from a developing country. Am J Med 2008;121:618–23.
   PubMed Web of Science ®Google Scholar
• Amare A, Zenebe G, Hammack J, Davey G. Status epilepticus: clinical presentation, cause, outcome and predictors of death in 119 Ethiopian patients. Epilepsia 2008;49:600–7.
   PubMed Web of Science ®Google Scholar
• Kalita J, Nair PP, Misra UK. A clinical, radiological and outcome study of status epilepticus from India. J Neurol 2010;257:224–9.
   PubMed Web of Science ®Google Scholar
• Tripathi M, Vibha D, Choudhary N, et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure 2010;19:109–11.
   PubMed Web of Science ®Google Scholar
• Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 1989;69:657–66.
   Web of Science ®Google Scholar
• Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendation s for therapy. Brain 2012;135:2314–28.
   PubMed Web of Science ®Google Scholar
• Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol 2006;536:102–8.
   PubMed Web of Science ®Google Scholar
• Nowack A, Yao J, Custer KL, Bajjalieh SM. SV2 regulates neurotransmitter release via multiple mechanisms. Am J Physiol Cell Physiol 2010;299:C960–7.
   PubMed Web of Science ®Google Scholar
• Deshpande LS, DeLorenzo RJ. Mechanisms of levetiracetam in the control of status epilepticus and epilepsy. Front Neurol 2014;5:1–5.
   PubMed Web of Science ®Google Scholar
• Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970–6.
   PubMed Web of Science ®Google Scholar
• Sivakumar S, Ibrahim M, Parker D Jr, et al. Clobazam: an effective add-on therapy in refractory status epilepticus. Epilepsia 2015;56(6):e83–9.
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J, Patel R. Sodium valproate vs. phenytoin in status epilepticus: a pilot study. Neurology 2006;67:340–2.
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol 2012;259:645–8.
   PubMed Web of Science ®Google Scholar
• Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631–7.
   PubMed Web of Science ®Google Scholar
• Riviello JJ Jr, Claassen J, LaRoche SM, et al. Neurocritical Care Society Status Epilepticus Guideline Writing Committee Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013;18:193–200.
   PubMed Web of Science ®Google Scholar
• Tiamkao S, Sawanyawisuth K, Chancharoen A. The efficacy of intravenous sodium valproate and phenytoin as the first-line treatment in status epilepticus: a comparison study. BMC Neurol 2013;13:98.
   PubMed Web of Science ®Google Scholar
• Chitsaz A, Mehvari J, Salari M, et al. A comparative assessment the efficacy of intravenous infusion of sodium valproate and phenytion in the treatment of status epilepticus. Int J Prev Med 2013;4:S216–21.
   PubMedGoogle Scholar
• Malamiri RA, Ghaempanah M, Khosroshahi N, et al. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur J Paediatr Neurol 2012;16:536–41.
   PubMed Web of Science ®Google Scholar
• Liu X, Wu Y, Chen Z, et al. A systematic review of randomized controlled trials on the therapeutic effect of intravenous sodium valproate in status epilepticus. Int J Neurosci 2012;122:277–83.
   PubMed Web of Science ®Google Scholar
• Wheless JW, Clarke D, Hovinga CA, et al. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study. J Child Neurol 2009;24:946–51.
   PubMed Web of Science ®Google Scholar
• Chen WB, Gao R, Su YY, et al. Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. Eur J Neurol 2011;18:1391–6.
   PubMed Web of Science ®Google Scholar
• Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011;52:1292–6.
   PubMed Web of Science ®Google Scholar
• Solomon T, Dung NM, Kneen R, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002;125:1084–93.
   PubMed Web of Science ®Google Scholar
• Misra UK, Kalita J. Seizures in Japanese encephalitis. J Neurol Sci 2001;190:57–60.
   PubMed Web of Science ®Google Scholar
• Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA (A) receptors, loss of inhibition, and a mechanism for pharmaco-resistance in status epilepticus. J Neurosci 2005;25:7724–33.
   PubMed Web of Science ®Google Scholar
• Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998;814:179–85.
   PubMed Web of Science ®Google Scholar
• Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 1997;17:7532–40.
   PubMed Web of Science ®Google Scholar
• French JA, Gazzola DM. Antiepileptic drug treatment: new drugs and new strategies. Continuum (Minneap Minn) 2013;19:643–55.
   PubMedGoogle Scholar